Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesPharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration - a pilot study
BMC Nephrology, 10/05/07
Anne-Cornelie J.M. de Pont, et al. - Danaparoid administered by a continuous infusion of 100 anti-Xa-U/h after a loading dose of 3500 anti-Xa-U elicited target anti-Xa levels from 2 - 12 h after the loading dose, without bleeding or thromboembolic events during the described CVVH treatment in suspected HIT patients
| Previous Article | Next Article |
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Forced Euvolemic Diuresis With Mannitol and Furosemide for Prevention of Contrast-Induced Nephropathy in Patients With CKD Undergoing Coronary Angiography: A Randomized Controlled Trial - Corrected Proof
American Journal of Kidney Diseases, 06/19/09
Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
American Journal of Kidney Diseases, 06/23/09
Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials
American Journal of Nephrology, 06/23/09
Article Search
Sponsor